Ghusn, Wissam
Boston Medical Center · Mayo Clinic
4 papers on CoChatORCID 0000-0002-9389-6795
Most cited papers
- Verified
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
Ghusn, W., De la Rosa, A., Sacoto, D., Cifuentes, L., Campos, A., Feris, F., Hurtado, M. D., & Acosta, A. (2022) · JAMA Network Open
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 238
- Verified
Glucagon-like receptor-1 agonists for obesity: weight loss outcomes, tolerability, side effects, and risks
Ghusn, W., & Hurtado, M. D. (2024) · Obesity Pillars
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 122
- Verified
Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study
Ghusn, W., Fansa, S., Anazco, D., Tama, E., Nicolalde, B., Gala, K., De la Rosa, A., Sacoto, D., Cifuentes, L., Campos, A., et al. (2024) · International Journal of Obesity
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 35
- Verified
Impact of metabolic and bariatric surgery on weight loss and insulin requirements in type 1 and insulin‐treated type 2 diabetes
Abi Mosleh, K., Salameh, Y., Ghusn, W., Jawhar, N., Mundi, M. S., Collazo‐Clavell, M. L., Kendrick, M. L., & Ghanem, O. M. (2024) · Clinical Obesity
Bariatric Surgery and OutcomesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free